Charles River Laboratories CEO Net Worth

Last Updated Mar 10, 2025
CEO NameJames C. Foster
NationalityUnited States
Net Worth Estimation$250 million

James C. Foster, CEO of Charles River Laboratories, has accrued an estimated net worth of around $250 million primarily through decades-long executive leadership, substantial equity holdings, stock grants, and performance-based compensation tied to the company's sustained market growth and acquisitions. His wealth is also influenced by significant stock sales documented in SEC filings and long-term appreciation in Charles River Laboratories' share price since he became CEO.

James C. Foster's estimated net worth of $250 million significantly exceeds the typical CEO range in the biotechnology sector, which ranges from $10 million to $80 million. His net worth is over 212% higher than the industry's maximum CEO net worth estimation.

Business Category: Biotechnology

Minimum Net Worth (estimation): 10000000 USD
Maximum Net Worth (estimation): 80000000 USD


James C. Foster Performance in Charles River Laboratories

James C. Foster, CEO of Charles River Laboratories, demonstrates strategic leadership and data-driven decision-making that drives innovation and operational efficiency. His performance is marked by expanding the company's global footprint and enhancing research and development capabilities. Foster's impact is evident in sustained revenue growth and strengthened market position within the life sciences sector.


Latest News

Charles River Laboratories Forms Scientific Advisory Board to Advance Non-Animal Testing Methods

Charles River Laboratories announced the creation of a global Scientific Advisory Board led by Dr. Namandje N. Bumpus, former FDA Chief Scientist, to accelerate development of alternative testing methodologies that reduce reliance on animal studies. The company also reported strong Q2 2025 earnings, exceeding analyst expectations, and CEO James C. Foster's employment agreement was recently extended through 2027, underscoring leadership stability amid ongoing industry shifts.
Source: http://www.investing.com/news/company-news/charles-river-labs-forms-scientific-advisory-board-to-advance-nams-93CH-4289748



Disclaimer.
The information provided in this document is for general informational purposes only and is not guaranteed to be complete. While we strive to ensure the accuracy of the content, we cannot guarantee that the details mentioned are up-to-date or applicable to all scenarios. Topics about Charles River Laboratories are subject to change from time to time.

Comments

No comment yet